Program details
-
Heterogeneity and subclassification of diabetes
Redefining diabetes: from heterogeneity to precision medicine
Chair(s): Sin Gon Kim, Rury R. Holman
Friday 16 October, 09:00~10:20
Room 4
-
Diabetes heterogeneity is increasingly recognized as a key determinant of disease mechanisms, progression, and complications. This session highlights how genetic, genomic, and multi-omic approaches are redefining diabetes subtypes, with particular emphasis on East Asian populations and diabetic kidney disease. These advances will accelerate precision diabetes research and support more individualized prevention and treatment strategies.
-
-
S03-L1
Stephen S. RichUniversity of Virginia, USA
-
Genetic architecture and heterogeneity in type 1 diabetes: from GWAS to functional insights
-
S03-L2
Wayne Huey-Herng SheuNational Health Research Institutes, Taiwan
-
Heterogeneity and subclassification of diabetes in Asians
-
S03-L3
Jae Hyun BaeSeoul National University, Korea
-
Genomic and multi-omic insights into the heterogeneity of diabetic kidney disease
-
Revitalizing beta-cell function in diabetes
Beta-cell dysfunction, preservation, and recovery in diabetes
Chair(s): Kyu Jeung Ahn, Byung Joon Kim
Saturday 17 October, 09:00~10:20
Room 4
-
This session will explore beta-cell dysfunction, preservation, and recovery in diabetes, integrating clinical features in Asian type 2 diabetes, glucocentric strategies for beta-cell preservation, and emerging quantitative imaging approaches to stress-adaptive beta-cell remodeling. The session will highlight how mechanistic insights can be translated into more precise strategies to restore beta-cell health and alter the trajectory of diabetes.
-
-
S13-L1
Nam Hoon KimKorea University, Korea
-
Characteristics of beta-cell dysfunction in Korean T2D
-
S13-L2
Kyuchang WonYeungnam University, Korea
-
Glucocentric view of beta-cell preservation
-
S13-L3
Takaaki MurakamiKyoto University, Japan
-
Toward β-cell recovery in diabetes: quantitative imaging and stress-adaptive β-cell remodeling
- Panel discussion
-
-
S13-P1
Joonyub LeeThe Catholic University of Korea, Korea
-
S13-P2
Jae-Han JeonKyungpook National University, Korea
-
S13-P3
Joon Ho MoonSeoul National University, Korea
-
Diabetes in Asia
Lean and nonobese diabetes: epidemiology, phenotype, and clinical features across Asian populations
Chair(s): Sungrae Kim, Lee-Ling Lim
Saturday 17 October, 15:00~16:20
Room 4
-
Lean and nonobese diabetes represents a distinctive phenotype increasingly recognized across Asian populations, where metabolic dysfunction emerges independently of obesity. This session explores the epidemiological characteristics and underlying pathophysiology of lean diabetes across East and South Asia, examines secondary etiologies contributing to its heterogeneity, and presents longitudinal trends in prevalence and clinical features over two decades in Korea. By integrating multi-national perspectives and diverse clinical evidence, this session aims to redefine diagnostic frameworks and therapeutic strategies beyond the conventional obesity-centric paradigm, ultimately advancing precision care for the rapidly growing population with lean or nonobese diabetes throughout Asia.
-
-
S17-L1
Yuji YamazakiKansai Electric Power Medical Research Institute, Japan
-
Characteristics of diabetes in East Asia with a focus on nonobese phenotype
-
S17-L2
Banshi SabooDiabetes Care & Hormone Clinic, India
-
Lean diabetes in South Asians: what exactly is it?
-
S17-L3
Lee-Ling LimUniversiti Malaya, Malaysia
-
Secondary causes of diabetes
-
S17-L4
Ju Hee LeeChungnam National University, Korea
-
Lean diabetes: 20-year trends in its prevalence and clinical features among Korean adults
- Panel discussion
-
-
S17-P1
Hae Jin KimAjou University, Korea
-
S17-P2
Ji Hye HeoHallym University, Korea
